Head-to-head · Cost-Efficiency Index
Cabana vs Remedy Meds
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Cabana
Shoppers who want a lifestyle-branded concierge wellness experience bundling GLP-1 with other treatments.
Visit CabanaRemedy Meds
Shoppers who don't mind completing an intake quiz before seeing pricing, and who want a stated month-to-month cancel-anytime commitment.
Visit Remedy MedsThe verdict
Cabana takes it, leading the Cost-Efficiency Index 40 to 39. Cabana is a concierge wellness brand offering compounded GLP-1 semaglutide and tirzepatide (injections and a semaglutide tablet) alongside NAD+ energy products, advertised from $249/month. Remedy Meds still earns a C — Shoppers who don't mind completing an intake quiz before seeing pricing, and who want a stated month-to-month cancel-anytime commitment.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs Cabana.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Cabana | Remedy Meds |
|---|---|---|
| Cost-Efficiency Index | 40/100 | 39/100 |
| Semaglutide / mo | Not disclosed | Not disclosed |
| Tirzepatide / mo | Not disclosed | Not disclosed |
| Semaglutide / yr (modeled) | — | — |
| Tirzepatide / yr (modeled) | — | — |
| Coverage | Coverage not published | Coverage not published |
| Oral / sublingual | Yes | No |
| Brand-name access | Yes | Yes |
| Rank here | #525 | #529 |
Cabana
40/100Where the value is
- Offers a semaglutide tablet option in addition to injectables
- Single, findable headline price ($249/mo starting) visible without an account
- Explicit disclaimer distinguishing FDA-approved vs. compounded (non-FDA-approved) medications
The tradeoffs
- Pricing is not broken out by specific drug or dose -- unclear what a semaglutide vs. tirzepatide patient actually pays
- 'Starting At' framing with no clarification of whether $249 is promotional or standard
Remedy Meds
39/100Where the value is
- Explicitly month-to-month with no long-term commitment stated ('Cancel anytime')
- LegitScript badge displayed
- Both compounded and brand-name (Ozempic/Zepbound) options offered, including a microdose plan
The tradeoffs
- No pricing published anywhere on the public site -- all figures gated behind an intake quiz
- No medical director or named compounding pharmacy disclosed
Regulatory note: the FDA issued a warning letter to Remedy Meds in September 2025. We still list and link to Remedy Meds; you should know the letter is on the public record before you decide.
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.